Journals / Klinik Tıp Bilimleri / 2019 / Cilt: 7 - Sayı: 3

Fat and Proteins in Medical Nutritional Therapy of Obese Diabetic Patients with Overweight and Obesity

Obez Diyabetik Bireylerin Tıbbi BeslenmeTedavisi Planlarında Yağ ve Protein

Pages
1–5
Publication Date
2019-04-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Thepurpose of this review is to address the effects of different macronutrients, such as protein and fat ratio, in patients with type 2 diabetes who are also obese or overweight.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:AbstractType 2 diabetes is the most frequently seen form of diabetes mellitus which is a heterogeneous disease highly epidemic in our country and all around the world.
📊
Key Findings & Data:Accordingto the data from the International Diabetes Foundation (IDF), today the number of people living with diabetes is 425 million all around the world and this number will riseto 629 million in the year 2045.
💡
Conclusion & Impact:Thepurpose of this review is to address the effects of different macronutrients, such as protein and fat ratio, in patients with type 2 diabetes who are also obese or overweight.
🔬Design:Review & Systematic Survey
📍Scope:2045 Verileri
⚙️Variables:diyabet · beslenme · prote-in

Abstract

AbstractType 2 diabetes is the most frequently seen form of diabetes mellitus which is a heterogeneous disease highly epidemic in our country and all around the world. Accordingto the data from the International Diabetes Foundation (IDF), today the number of people living with diabetes is 425 million all around the world and this number will riseto 629 million in the year 2045. It is evident that multiple factors play a role in the etiology of type 2 diabetes. Healthy nutrition and exercise are the "sine qua non" of diabetes treatment. Although there are several standards related to the type of nutrition of patients with type 2 diabetes, the pattern or ratio of macronutrients in the diets prescribedto people with diabetes who are either overweight or obese is still a controversial. Thepurpose of this review is to address the effects of different macronutrients, such as protein and fat ratio, in patients with type 2 diabetes who are also obese or overweight.

Özet

ÖzBugün ülkemizde ve tüm dünya’ da salgın hastalık tanımıyla ele alınan, heterojen bir hastalık olan diyabetin en bilinen ve en sık görülen formu tip 2 diyabettir (1). Uluslararası Diyabet Vakfı (IDF) verilerine göre; 2017 yılında tüm dünya’ da 425 milyon diyabetli birey bulunurken 2045 yılında bu sayının 629 milyon kişiye ulaşacağı öngörülmektedir (2). Etiyolojisinde pek çok faktörün etkili olduğu düşünülen tip 2 diyabetin tedavisinin birinci basamağında sağlıklı beslenme ve/veya yanlış beslenme alışkanlıklarının düzeltilmesi ve egzersiz önerilerinin devamlılığı ön plana çıkmaktadır. Tip 2 diyabetli bireylerin beslenme ilkelerine ilişkin pek çok dernek ve otorite tarafından kabul görmüş bazı standartlar bulunmakta fakat fazla kilolu diyabetik bireylerin diyetlerindeki besin örüntüsü ya da oranları konusu hala tartışılmaktadır. Bu çalışmanın amacı obez diyabetik bireylerin diyetlerindeki makro besin ögelerden olan protein ve yağ oranlarının güncel çalışmalar ışığında sağlığa olan etkilerini derlemektir.

🔖

Cite This Article

KESER, A. (2019). Fat and Proteins in Medical Nutritional Therapy of Obese Diabetic Patients with Overweight and Obesity. Klinik Tıp Bilimleri, Cilt: 7 - Sayı: 3, 1–5. https://ajindex.com/articles/838217

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Kaynaklar 1.World Health Organization. Global Status Report on Noncommunicab-le Diseases 2014. 2.IDF Diabetes Atlas.8th ed2017. 3.Diabetes Mellitus ve Komplikasyonlarının Tanı,Tedavi ve İzlem Kılavu-zu 2017. Türkiye Endokrinoloji ve Metabolizma Derneği (TEMD). 4.Dinçdağ N (Ed.)Temel Endokrinoloji ve Diyabet. EMA Tıp Kitabevi Ya-yıncılık.,2016. 5.Tüzün M. Endokrinoloji El Kitabı, Kabalak T,Yılmaz C,Tüzün M,Çetin-kalp Ş(Ed.).Diyabet ve Prediyabetin Tanımı,Tanısı ve Sınıflama-sı.2013
  2. Şevki Çetinkalp.Endokrinoloji El Kitabı, Kabalak T,Yılmaz C,Tüzün M,Çe-tinkalp Ş(Ed.).Tip 2 Diabetes Mellitus.2013
  3. Metin Aslan. Endokrinoloji El Kitabı, Kabalak T,Yılmaz C,Tüzün M,Çe-tinkalp Ş(Ed.).Diabetes Mellitus Tedavisi.2013
  4. Identifying patients at risk: ADA’s definitions for nutrition screening andnutrition assessment. J Am Diet Assoc.1994
  5. 94 (8):838–9. 9.American Diabetes Association. 3. Foundations of care and comprehen-sive medical evaluation. Diabetes Care. 2016
  6. 39 (Suppl 1):23–35. 10.Franz MMJ, Powers MA, Leontos C, et al. The evidence for medical nut-rition therapy for type 1 and type 2 diabetes in adults. J Am Diet As-soc.2010
  7. 110(12):1852–89. 11.Rivellse A,Giacco R,Costabile G.Dietary Carbohydrates for Diabetics.CurrAthersoscler Rep. 2012
  8. American Diabetes Association. Standarts of medical care in diabetes.Dia-betes care.2009
  9. 32 suppl 1:13-61. 13.Evert AB, Boucher JL, Cypress M, et al. Nutrition therapy recommen-dations for the management of adults with diabetes. DiabetesCare.2013
  10. 36(11):3821–42. 14.Canadian Diabetes Association Clinical Practice Guidelines ExpertCom-mittee. Canadian Diabetes Association clinical practice guidelines forthe prevention and management of diabetes in Canada. Can J Diabe-tes.2013
  11. 37(Suppl 1):S1–212. 15.Diabetes Prevention Program Research GroupKnowler WC, Fowler SE,Hamman RF, et al. 10-year follow-up of diabetes incidence and weightloss in the Diabetes Prevention Program Outcomes Study. Lancet2009
  12. Published erratum in: Lancet. 2009
  13. Lindström J, Ilanne-Parikka P, Peltonen M, et al, Finnish Diabetes Pre-vention Study Group. Sustained reduction in the incidence of type 2 dia-betes by lifestyle intervention: follow-up of the Finnish Diabetes Preven-tion Study. Lancet.2006
  14. Joslin Diabetes Centre, Joslin Clinic. Clinical nutrition guideline for overwe-ight and obese adults with type 2 diabetes, prediabetes or those at high riskof developing type 2